Hudson Bay Capital Management’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-716,613
| Closed | -$7.23M | – | 1116 |
|
2022
Q4 | $7.23M | Hold |
716,613
| – | – | 0.07% | 224 |
|
2022
Q3 | $7.1M | Buy |
716,613
+99,612
| +16% | +$987K | 0.06% | 240 |
|
2022
Q2 | $6.05M | Hold |
617,001
| – | – | 0.05% | 314 |
|
2022
Q1 | $6.05M | Hold |
617,001
| – | – | 0.08% | 279 |
|
2021
Q4 | $6M | Hold |
617,001
| – | – | 0.06% | 269 |
|
2021
Q3 | $5.98M | Sell |
617,001
-4,749
| -0.8% | -$46K | 0.08% | 261 |
|
2021
Q2 | $6.01M | Buy |
+621,750
| New | +$6.01M | 0.07% | 266 |
|